Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Arch Dis Child Fetal Neonatal Ed ; 83(2): F130-4, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10952708

RESUMO

AIM: To examine in vitro the effects of brief contact with various infusion solutions on red blood cells from newborn infants, as occurs in the "waste" syringe during routine blood sampling from umbilical artery catheters. The mixture of blood and solution in the "waste" syringe is usually reinfused into the baby. Reinfused red blood cells may be damaged by the infusion solution. It is hypothesised that an isotonic amino acid solution would cause no red blood cell agglutination and no more haemolysis than many commonly used solutions. METHODS: Blood was obtained from the placentas of 15 normal term babies. Haemolysis was estimated by measuring plasma (free) haemoglobin after mock blood sampling. Agglutination was measured semiquantitatively by direct observation. RESULTS: A 0.25% normal saline solution caused 5.4% haemolysis, significantly more than all the other fluids tested. There was less haemolysis with 0. 25% normal saline when there was complete mixing of blood and solution within the "waste" syringe. Normal saline and isotonic sodium acetate solutions caused < 0.1% haemolysis, significantly less than all the other fluids tested. The isotonic amino acid solution caused 0.8% haemolysis, which is similar to that caused by the remaining solutions tested. Agglutination was seen with isotonic dextrose and with the two isotonic amino acid solutions containing cysteine. CONCLUSIONS: Isotonic amino acid solution (without added cysteine) caused no agglutination and the same or less haemolysis than many commonly used solutions and may offer advantages in nutrition and fluid balance.


Assuntos
Eritrócitos/efeitos dos fármacos , Infusões Intra-Arteriais/efeitos adversos , Testes de Aglutinação , Aminoácidos/efeitos adversos , Cisteína/efeitos adversos , Feminino , Sangue Fetal , Glucose/efeitos adversos , Hemólise/fisiologia , Humanos , Recém-Nascido , Soluções Isotônicas , Placenta/efeitos dos fármacos , Gravidez , Acetato de Sódio/efeitos adversos , Cloreto de Sódio/efeitos adversos
9.
Am J Med Genet ; 34(3): 445-50, 1989 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-2688423

RESUMO

Craniofrontonasal dysostosis (CFND) is an inherited disorder previously referred to as craniofrontonasal dysplasia. However, there is no evidence of tissue dysplasia and, therefore, the term dysostosis has been substituted. The disorder is characterized by frontonasal dysostosis, coronal craniostenosis, and the variable presence of other skeletal defects, including short webbed neck, sloping shoulders, polydactyly, syndactyly, and broad first toes. Here we report an affected mother and daughter who also have limited hip abduction. In addition, the mother had an axillary pterygia, congenital footplate fixation of the left ear, and right sensorineural hearing loss; these manifestations have not been reported previously in CFND and expand the phenotype of this syndrome. Both patients had marked restriction of shoulder abduction, and the mother had limited forearm pronation; these manifestations have been reported in only one other patient with CFND. Awareness of the possibility of these abnormalities may allow for early intervention by physical therapy and hearing aides in infants and young children with these manifestations as a component of CFND.


Assuntos
Anormalidades Múltiplas/genética , Disostose Craniofacial/genética , Perda Auditiva Neurossensorial/genética , Deficiência Intelectual/genética , Adulto , Feminino , Genes Dominantes , Humanos , Recém-Nascido , Ossos Pélvicos/anormalidades , Ombro/anormalidades , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA